Using pH-sensitive hydrogels containing cubane as a crosslinking agent for oral delivery of insulin

被引:29
作者
Mahkam, M [1 ]
机构
[1] Azarbaijan Univ Tarbiat Moallem, Fac Sci, Dept Chem, Tabriz 5375171379, E Azarbaijan, Iran
关键词
hydrogel; swelling; oral delivery; insulin; cubane;
D O I
10.1002/jbm.b.30279
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
The goal of oral insulin delivery devices is to protect the sensitive drug from proteolytic degradation in the stomach and upper portion of the small intestine. Copolymers of 2-hydroxyethyl methacrylate (HEMA) and methacrylic acid (MAA) based hydrogels containing 2, 4, and 6% of a crosslinking agent (CA) were studied as drug delivery systems. Cubane-1, 4-dicarboxylic acid (CDA) was linked to two HEMA groups as CA. Radical copolymerizations of HEMA and MAA with the various ratios of CA were performed at 70 degrees C. The compositions of the crosslinked three-dimensional polymers were determined using Fourier transform infrared spectroscopy. Glass-transition temperature of the network polymers was determined calorimetrically. The effect of copolymer composition on the swelling behavior and hydrolytic degradation was studied in simulated gastric fluid (pH 1) and simulated intestinal fluid (pH 7.4). The swelling and hydrolytic behavior of the copolymers was dependent on the content of MAA groups and caused a decrease in gel swelling in simulated gastric fluid or an increase in gel swelling in simulated intestinal fluid. The drug-release profiles indicate that the amount of drug release depends on their degree of swelling and crosslinking. (c) 2005 Wiley Periodicals, Inc.
引用
收藏
页码:108 / 112
页数:5
相关论文
共 17 条
[1]   SOLUBILITY EFFECTS ON DRUG TRANSPORT THROUGH PH-SENSITIVE, SWELLING-CONTROLLED RELEASE SYSTEMS - TRANSPORT OF THEOPHYLLINE AND METOCLOPRAMIDE MONOHYDROCHLORIDE [J].
BETTINI, R ;
COLOMBO, P ;
PEPPAS, NA .
JOURNAL OF CONTROLLED RELEASE, 1995, 37 (1-2) :105-111
[2]  
CAMPBELL RK, 1993, NEW OPPORTUNITIES DI
[3]   Synthesis and characterization of pH-sensitive dextran hydrogels as a potential colon-specific drug delivery system [J].
Chiu, HC ;
Hsiue, GH ;
Lee, YP ;
Huang, LW .
JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION, 1999, 10 (05) :591-608
[4]   Peroral delivery systems based on superporous hydrogel polymers: release characteristics for the peptide drugs buserelin, octreotide and insulin [J].
Dorkoosh, FA ;
Verhoef, JC ;
Ambagts, MHC ;
Rafiee-Tehrani, M ;
Borchard, G ;
Junginger, HE .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2002, 15 (05) :433-439
[5]   Oral controlled release technology for peptides: Status and future prospects [J].
Fix, JA .
PHARMACEUTICAL RESEARCH, 1996, 13 (12) :1760-1764
[6]   Novel crosslinking methods to design hydrogels [J].
Hennink, W. E. ;
van Nostrum, C. F. .
ADVANCED DRUG DELIVERY REVIEWS, 2012, 64 :223-236
[7]   POLYMERS FOR COLON-SPECIFIC DRUG DELIVERY [J].
KOPECEK, J ;
KOPECKOVA, P ;
BRONDSTED, H ;
RATHI, R ;
RIHOVA, B ;
YEH, PY ;
IKESUE, K .
JOURNAL OF CONTROLLED RELEASE, 1992, 19 (1-3) :121-130
[8]   Extrusion-spheronization of pH-sensitive polymeric matrix pellets for possible colonic drug delivery [J].
Krogars, K ;
Heinämäki, J ;
Vesalahti, J ;
Marvola, M ;
Antikainen, O ;
Yliruusi, J .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2000, 199 (02) :187-194
[9]   The challenge of proteolytic enzymes in intestinal peptide delivery [J].
Langguth, P ;
Bohner, V ;
Heizmann, J ;
Merkle, HP ;
Wolffram, S ;
Amidon, GL ;
Yamashita, S .
JOURNAL OF CONTROLLED RELEASE, 1997, 46 (1-2) :39-57
[10]  
Lee VH, 1991, PEPTIDE PROTEIN DRUG, P691